Can We Rationalize Oral Drug Exposure Following Bariatric Surgery to Meet the Pharamacotherapeutic Needs of a Growing Patient Population? Commentary on: “Lithium Toxicity Following Roux-en-Y Gastric Bypass”

Adam S. Darwich; Amin Rostami-Hodjegan

doi:10.1089/bari.2014.9960

Can We Rationalize Oral Drug Exposure Following Bariatric Surgery to Meet the Pharamacotherapeutic Needs of a Growing Patient Population? Commentary on: “Lithium Toxicity Following Roux-en-Y Gastric Bypass”

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	81-83
Number of pages	2
Journal	Bariatric Surgical Practice and Patient Care
Volume	9
Issue number	2
DOIs	https://doi.org/10.1089/bari.2014.9960
Publication status	Published - 1 Jun 2014

Keywords

bariatric surgery
pharmacokinetics

Access to Document

10.1089/bari.2014.9960

http://www.liebertpub.com/overview/bariatric-nursing-and-surgical-patient-care/172/

Cite this

@article{cd51357d7d3f4118803da7bff0a201b6,

title = "Can We Rationalize Oral Drug Exposure Following Bariatric Surgery to Meet the Pharamacotherapeutic Needs of a Growing Patient Population? Commentary on: “Lithium Toxicity Following Roux-en-Y Gastric Bypass”",

keywords = "bariatric surgery, pharmacokinetics",

author = "Darwich, {Adam S.} and Amin Rostami-Hodjegan",

year = "2014",

month = jun,

day = "1",

doi = "10.1089/bari.2014.9960",

language = "English",

volume = "9",

pages = "81--83",

journal = "Bariatric Surgical Practice and Patient Care",

issn = "2168-0248",

publisher = "Mary Ann Liebert Incorporated",

number = "2",

}

Can We Rationalize Oral Drug Exposure Following Bariatric Surgery to Meet the Pharamacotherapeutic Needs of a Growing Patient Population? Commentary on: “Lithium Toxicity Following Roux-en-Y Gastric Bypass”. / Darwich, Adam S.; Rostami-Hodjegan, Amin.
In: Bariatric Surgical Practice and Patient Care, Vol. 9, No. 2, 01.06.2014, p. 81-83.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Can We Rationalize Oral Drug Exposure Following Bariatric Surgery to Meet the Pharamacotherapeutic Needs of a Growing Patient Population? Commentary on: “Lithium Toxicity Following Roux-en-Y Gastric Bypass”

AU - Darwich, Adam S.

AU - Rostami-Hodjegan, Amin

PY - 2014/6/1

Y1 - 2014/6/1

KW - bariatric surgery

KW - pharmacokinetics

U2 - 10.1089/bari.2014.9960

DO - 10.1089/bari.2014.9960

M3 - Article

SN - 2168-0248

VL - 9

SP - 81

EP - 83

JO - Bariatric Surgical Practice and Patient Care

JF - Bariatric Surgical Practice and Patient Care

IS - 2

ER -